Delivery Order SPE2DB22D1200-SPE2DB25FN2WE
Award Date
6/30/25
Potential Completion Date
7/1/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azelastine HCL 0.05% Drops in 6ml containers, with a ceiling value of $1,456.46 and a completion date of July 1, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,523.57, is for the delivery of Azelastine 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of June 26, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,751,027 units of the drug Azelastine HCL 0.05% Drops in 6 mL bottles. The fixed-price delivery order, valued at $3,475.53, has an ultimate completion date of April 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) through...
This federal contract award, identified as SPE2DB20D2200|SPE2DB25FW65C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,392.26, is a delivery order for the supply of 4567713430 - AZELASTINE HCL 0.05% DROPS 6ML. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, valued at $1,245.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Azelastine 0.1% (137 MCG) spray medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.05 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,884.78, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
The Defense Logistics Agency Troop Support Medical awarded a $952 delivery order to Amerisourcebergen Drug Corp for 4561522412 AZELASTINE HCL 0.05% DROPS 6ML. The firm fixed price order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania location over a one day period from July 17 through July 18, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for azelastine hydrochloride nasal drops supports the Agency's mission to...
This contract award is for the delivery of Azelastine 0.1% (137 mcg) spray, 30 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $1,415.26. The contract is structured as a Firm Fixed Price Delivery Order, with a period of performance through September 26, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a $1,102.99 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of AZASITE 1% eye drops. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The...